Fact CheckerSign in

NCT06768645Completed

The Effectiveness of Diabetic Foot Wound Prevention Training

The Effectiveness of Diabetic Foot Wound Prevention Training Given With Pecha Kucha (20*20) Presentation Technique: A Randomized Controlled

Source: ClinicalTrials.gov · Last updated 10 Jan 2025

Brief summary (registry, in English)

This study aimed to evaluate the impact of diabetic foot care training delivered using the Pecha Kucha (20\*20) presentation method on the knowledge, self-efficacy, and behavior levels of patients with Type 2 diabetes. Conducted between December 10, 2023, and October 7, 2024, this randomized controlled experimental study included 125 diabetic individuals, with 62 in the experimental group and 63 in the control group. The experimental group received diabetic foot care education using the Pecha Kucha method, while the control group received conventional education. Data were collected using the Patient Assessment Form, Diabetes Foot Knowledge Questionnaire, Diabetic Foot Care Self-Efficacy Scale, and Foot Self-Care Behavior Scale.

Status (registry)
Completed
Study type
Interventional
Enrollment
125 (actual)
First submitted
29 Dec 2024
Start date
Dec 2023
Primary completion date
Jun 2024
Lead sponsor
Istanbul Medeniyet University
NCT number
NCT06768645

What you commit to

  • Study type: Interventional
  • Participants enrolled: 125
  • From Dec 2023 to the primary completion date, Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • presence of advanced retinopathy, violation of inclusion criteria, withdrawal of consent by the patient.

Who the study is looking for

  • diagnosis of type 2 diabetes according to the American Diabetes Association (ADA) criteria at least six months before the study
  • age 18 years or older, literacy in and ability to speak Turkish,
  • absence of communication/mental problems,
  • willingness to participate in the study.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
İstanbul
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.